CC - The Chemours Company
| Previous Close | 17.08 |
| Open | 16.84 |
| Bid | 16.39 x 800 |
| Ask | 18.60 x 1800 |
| Day's Range | 16.16 - 16.84 |
| 52 Week Range | 11.71 - 42.13 |
| Volume | 2,651,429 |
| Avg. Volume | 3,587,525 |
| Market Cap | 2.717B |
| Beta (3Y Monthly) | 2.33 |
| PE Ratio (TTM) | 4.78 |
| EPS (TTM) | 3.48 |
| Earnings Date | Oct 30, 2019 - Nov 4, 2019 |
| Forward Dividend & Yield | 1.00 (5.85%) |
| Ex-Dividend Date | 2019-08-15 |
| 1y Target Est | 22.46 |
- InvestorPlace
7 Stocks the Insiders Are Buying on Sale
[Editor's Note: This article is updated each week with the latest insider moves.]There are many reasons why an insider of a company may sell their stock. They may need to raise money for things such as a home purchase and a divorce settlement. However, there is only one reason why there would be insider buying of a stock. They believe that they will profit because it is currently undervalued.Insiders are people who have access to confidential information about a company. There have been numerous cases over the years where insiders take advantage of this in order to profit. For example, suppose an insider knows that news is about to be released that will make the stock go higher. The insider could buy it from a shareholder who does not have access to the news.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOne of the rules that the SEC has established to protect investors from this type of illicit activity is to require the insiders to publicly disclose when they are buying or selling their stock. This will help to prevent unethical insiders from taking advantage of uninformed investors.When I am thinking about buying a stock, I always like to see what the insiders are doing. I especially like to see if they are buying after the stock has seen a dramatic drop in price. This could be a sign that the stock is a good value at current levels. * 10 Recession-Resistant Services Stocks to Buy Here are seven stocks that insiders have been buying after they made large moves lower. The Chemours Company (CC)The Chemours Company (NYSE:CC) sells performance chemicals in markets all over the world.The price of CC stock has dropped from $40 a share to current levels around $16 since just this past April. This is due to the fact that the company has missed earnings estimates and reduced its guidance. Because of this, many of the firms that follow it on a research basis have reduced their ratings.Mark Newman is a Senior Vice President and the Chief Operating Officer of Chemours. He must believe that the stock is a great value at these levels because he just made a significant personal investment. Maybe he is attracted to the 6.1% dividend that the stock is currently yielding.On Sept. 11 he paid an average price of $16.42 for 20,000 shares. This was an investment of almost $330,000. Flowtek Industries Inc. (FTK)Flowtek Industries Inc. (NYSE:FTK) provides chemistry and other services to companies in the oil and gas industry.FTK stock dropped by about 40% in early August when shareholders were disappointed with earnings results. Before the report, shares were trading around $2.80. When the results were released, the stock fell to $2.The loss for the quarter was 21 cents. In fiscal 2018, the company reported a loss of $1.21 a share. This was significantly worse than the loss of 44 cents a share that was reported in 2017. * 10 Big IPO Stocks From 2019 to Watch David Nierenberg is a Director of the company. He must think that the sellers have overreacted to this news because he just made a substantial investment of almost $650,000. Between Sept. 10 and Sept. 12 Nierenberg acquired about 270,000 shares of stock. Signet Jewelers LTD. (SIG)Signet Jewelers LTD. (NYSE:SIG) sells jewelry, watches and other products.Like many other retailers, Signet has faced some challenges. This has caused the price of the stock to lose more than half of its value between March and early September.After reaching a 10-year low, SIG stock rallied after it reported earnings that were better than estimates. It also raised its guidance.Two insiders of this company must think that things are turning around and that this rally will continue. They each just made large purchases of the stock. Virginia Drosos is the CEO of Signet. She just made an investment of over $50,000 when she paid $14.14 for 4,000 shares.Joan Hilson is the Chief Financial Officer. She made an even larger investment when she bought 7,500 shares at $14.56 a share. This was almost $110,000. That's not chump change. Aerie Pharmaceuticals, Inc. (AERI)Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) develops and sells therapies for the treatment of eye diseases.Over the past year, the price of AERI stock dropped by more than 60%. Last September, shares traded for over $60 a share. This September, shares traded below $20.Because of this, there has been a significant amount of insider buying. Richard Rubino is the Chief Financial Officer of Aerie. He just invested $100,000 when he paid $19.93 for 5,040 shares.Vicente Anido is the CEO of the company. He must also be bullish on the long-term prospects. He just made an investment of $500,000 when he recently bought 26,000 shares. * 7 Dow Titans Breaking Higher Wall Street is also bullish on the company; 10 firms follow it and 9 of them have buy ratings on it. The average target price is around $63. This is almost 3 times higher than where it is currently trading. Phunware, Inc. (PHUN)Phunware, Inc. (NASDAQ:PHUN) provides multiscreen-as-a-service cloud platforms for mobile devices.Over the past few months, the price of PHUN stock has dropped from around $4 a share to as low as $1.14 in mid-August. Since then, it has had an impressive recovery and has rallied to current levels around $1.73.There have been some positive developments for Phunware. In July, the company announced that is had been added to the Russel Microcap index. In addition, it also announced that it has partnered with L&T Technology Services to implement its platform on a corporate campus for an undisclosed Fortune 50 company.Randal Crowder is the Chief Operating Officer of Phunware. He must believe that the stock will continue to rally. He recently bought almost 40,000 shares on the open market. There has been buying by other insiders as well. Nektar Therapeutics (NKTR)Nektar Therapeutics (NASDAQ:NKTR) develops drugs for cancer, autoimmune disease and chronic pain.Over the past year, the price of NKTR stock has dropped from $80 per share to current levels around $20. This could be because the company has reported losses in each of the last four quarters. In the most recent quarter, the loss for Nektar was 63 cents a share.Stephen Dobersten is a Senior Vice President and Chief Scientific Officer of the company. He must believe that the stock is a good value at these levels. He just invested $260,000 of his personal funds when he paid $17.28 for 15,000 shares. * 7 Momentum Stocks to Buy On the Dip The Street believes that the stock is undervalued as well; 13 firms follow NKTR stock. The average rating is overweight and the average target price is $39.45. This is almost twice as high as where it is currently trading. Meredith Corporation (MDP)Meredith Corporation (NYSE:MDP) operates as a diversified media company.MDP stock dropped by almost 25% in early September when the company reported earnings that disappointed investors. Since then it has recovered somewhat.Thomas Harty is the President and CEO of the company. He must believe that the sellers overreacted when they knocked the stock down. He just paid $35.02 for 12,000 shares. This was a personal investment of more than $420,000.Five Wall Street research firms follow Meredith and they seem to like it as well. The average rating is overweight. The average target price is $48.80. This is about 10 dollars higher than where it is currently trading. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Real Estate Investments to Ride Out the Current Storm * 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk * 7 Safe Dividend Stocks for Investors to Buy Right Now The post 7 Stocks the Insiders Are Buying on Sale appeared first on InvestorPlace.
- GuruFocus.com
The Chemours Co (CC) Senior VP & COO Mark Newman Bought $328,400 of Shares
Senior VP & COO of The Chemours Co (30-Year Financial, Insider Trades) Mark Newman (insider trades) bought 20,000 shares of CC on 09/11/2019 at an average price of $16.42 a share. Continue reading...
- Moody's
Pennsville (Township of) NJ -- Moody's assigns A1 to Pennsville, NJ's $8.9M GO bonds
Moody's Investors Service has assigned an A1 to the Township of Pennsville, NJ's $8.9 million Bonds consisting of $5.6 million General Bonds of 2019 and $3.3 million Tax Appeal Refunding Bonds of 2019. For provisional ratings, this announcement provides certain regulatory disclosures in relation to the provisional rating assigned, and in relation to a definitive rating that may be assigned subsequent to the final issuance of the debt, in each case where the transaction structure and terms have not changed prior to the assignment of the definitive rating in a manner that would have affected the rating.
- PR Newswire
Chemours' John Sworen Receives Moore Medal for Developing Non-Fluorinated Bio-Based Water Repellent
WILMINGTON, Del., Sept. 10, 2019 /PRNewswire/ -- John Sworen, a Technical Fellow at The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today will receive the 2019 SCI Gordon E. Moore Medal for leading a team that developed Teflon EcoElite™, a non-fluorinated, renewably sourced durable repellent for use in the consumer textile market. The development of Teflon EcoElite™ finish is part of Chemours' broader pledge to develop products with industry-leading sustainability profiles. The Moore Medal is awarded by The Society of Chemical Industry (SCI), America Group, and recognizes early career success in innovation, as reflected both in market impact and improvement to the quality of life.
- PR Newswire
Chemours Achieves National Certification as a Great Place to Work® for a Second Straight Year
WILMINGTON, Del., Sept. 6, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies and chemical solutions, today proudly announced that for a second straight year the company has been certified as a Great Place to Work®. The prestigious national certification is based on validated employee feedback captured through an anonymous online survey that measures attributes of a company's culture.
- Simply Wall St.
Read This Before Buying The Chemours Company (NYSE:CC) Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
- Zacks
Chemours (CC) Down 22% Since Last Earnings Report: Can It Rebound?
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Thomson Reuters StreetEvents
Edited Transcript of CC earnings conference call or presentation 2-Aug-19 12:30pm GMT
Q2 2019 Chemours Co Earnings Call
- American City Business Journals
DuPont to end use of some PFAS chemicals this year
DuPont will stop using controversial PFAS chemicals in its operations by the end of the year, the Wilmington-based company announced Wednesday. PFAS — a group of chemicals used in the production of things like Teflon and firefighting foam — has been associated with serious health problems as the resilient chemicals don’t break down naturally in the environment or the human body. It will also offer royalty-free licenses for DuPont’s proprietary PFAS water-treatment technology and bring in external experts who will review its use and handling of “substances of concern.” DuPont’s announcement comes about two weeks before the House of Representatives’ Oversight and Reform Committee’s environmental subcommittee plans to hold a hearing on PFAS contamination, Chemical and Engineering News reported.
- Simply Wall St.
How Much Did The Chemours Company's (NYSE:CC) CEO Pocket Last Year?
In 2015 Mark Vergnano was appointed CEO of The Chemours Company (NYSE:CC). This analysis aims first to contrast CEO...
- ACCESSWIRE
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
NEW YORK, NY / ACCESSWIRE / August 17, 2019 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (CC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Chemours and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
- American City Business Journals
Philadelphia companies hit hard by sharp stock market declines
Among the Philadelphia region’s largest 20 publicly traded companies, the biggest losers were two chemical companies.
- InvestorPlace
10 Cheap Dividend Stocks to Load Up On
Although the market's near-7% setback suffered since its late-July high is neither devastating nor unusual, it has certainly been frustrating all the same. Many investors who were lured into the idea of "chasing performance" ended up being punished for doing so, even with Tuesday's bounce.The selloff isn't necessarily a reason to throw in the towel altogether though. Indeed, for income-minded investors willing to forego some excitement in the name of consistency will find the marketwide weakness has up-ended even some of the highest-quality dividend stocks. Many of these names can not only be purchased at below-average valuation, but at above-average yields. Your return on these cheap stocks to buy is based on your entry price. * 15 Growth Stocks to Buy for the Long Haul To that end, here's a rundown of ten dividend stocks to buy while the market's bearish tide has made them too cheap to ignore. They may not be at their absolute bottom yet, but they've given up far more ground than they ever should have been allowed to give up.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cheap Dividend Stocks to Buy: Pfizer (PFE)Source: Kojach Via FlickrDividend Yield: 3.96% Forward Price-to-Earnings Ratio: 12.6Pfizer (NYSE:PFE) can be considered cheap for one simple reason. That is, it's down nearly 20% year-to-date, reaching a 14-month low on Monday.The most recent portion of that weakness stems from the decision to sell its "off-patent" Upjohn division to rival drugmaker Mylan (NASDAQ:MYL), though clearly investors were losing interest -- and faith -- in PFE stock well before that announcement was made late last month. The expiration of key patents on blockbuster drug Lyrica has also weighed on investors' minds, as has a broad uncertainty over which piece of the healthcare market will bear the bulk of the burden for lowering costs.The doubters may have overshot their target though. Pfizer is now yielding 3.96%, and trades at only 12.6 times its (pre-spinoff) 2020 earnings. Chemours Co (CC)Source: Shutterstock Dividend Yield: 8% Forward P/E: 2.9The bulk of the recent weakness Chemours Co (NYSE:CC) shares have demonstrated reflects a potential legal liability related to its manufacture of perfluorochemicals (PFAs) which are used to make, among other things, Teflon cookware.The company's woes go well beyond that one stumbling block though. North America's titanium dioxide market is also running into a headwind, hitting Chemours in where it hurts the most. Its fiscal second-quarter titanium dioxide fell 35% year-over-year. * 10 Stocks Under $5 to Buy for Fall The worst-case scenario may well be fully priced in, however. Although this year is set to be a tough one, analysts are modeling an 11% turnaround in next year's revenue, prompting a sizeable recovery of this year's 52% earnings decline. The stock's yielding 8% in the meantime, on a dividend the company makes a point of paying if at all possible. AES (AES)Source: Shutterstock Dividend Yield: 3.6% Forward P/E: 10.6The second-quarter report from utility name AES (NYSE:AES) was anything but thrilling. Not only did income of 26 cents per share fall short of the 27 cents per share analysts were expecting, revenue was down a little more than 2%.The subsequent pullback added to an existing selloff. AES stock is now down nearly 17% from its March high, as the market seeks to right-price this otherwise reliable player in an unclear interest rate environment.For the most part, investors are forgetting that while it's not a high-growth vehicle, like most utility names, this one's rather well shielded from economic ebbs and flows that could disrupt its dividend … a dividend that has not failed to grow in any year since 2013. Molson Coors Brewing (TAP)Source: Drew Stephens via FlickrDividend Yield: 4.4% Forward P/E: 11.8For a handful of reasons, Molson Coors Brewing (NYSE:TAP) has been unable to restore its former greatness. The name behind not just Coors and Molson, but brands like Blue Moon, Ice House and Miller, just hasn't resonated with consumers like it did in the past. Beer drinkers are now opting for something else, particularly in the United States where it desperately needs to thrive. * 10 Real Estate Investments to Ride Out the Current Storm The full extent of the headwind may have already done all the damage it could do though. Next year's sales should essentially be flat, and the earnings decline is finally expected to abate; 2020's projected income of $4.48 per share is only a tiny fraction better than this year's likely bottom line of $4.45. But, that's enough (and then some) to fund the dividend going forward. It has only paid out $1.63 over the course of the past four quarters. The Carlyle Group (CG)Source: Shutterstock Dividend Yield: 6.5% Forward P/E: 8.7Technically speaking it's not a stock. Nevertheless, The Carlyle Group (NASDAQ:CG) has earned a spot on a list of cheap dividend stocks to buy because the yield of 6.5% is well above the market's average at this time. The S&P 500, for perspective, is yielding right around 1.9%.The Carlyle Group is usually categorized as an asset management outfit, although that's not quite what it does. The organization is a private equity and business-development player. It owns equity in, lends money to or outright owns smaller companies that may not otherwise be accessible to investors through a publicly-traded instrument.It's a structure that's ideal for dividend payments. Inasmuch as its portfolio of companies don't have public shareholders themselves, these businesses can be managed first and foremost with cash flow in mind. Seagate Technology (STX)Source: Shutterstock Dividend Yield: 5.6% Forward P/E: 9.3Much like its peer Micron Technology (NASDAQ:MU), in 2018 Seagate Technology (NASDAQ:STX) found itself to be a victim of a glut it helped create. With an exaggerated response to demand at the time, chip manufacturers ramped up their output of volatile memory (RAM) as well as data-storage drives that largely destroyed their pricing power.That glut finally appears to be abating. Although just barely, prices for NAND and DRAM have stopped falling, and have begun logging higher highs. * 7 Education Stocks to Buy for the Future of Academia Micron is certainly a bargain too, now that there's a light at the end of the tunnel. Seagate Technology is the better dividend name, however, yielding 5.6% and priced at less than ten times next year's expected earnings. Cardinal Health (CAH)Source: Via WikimediaDividend Yield: 4.4% Forward P/E: 8.6Cardinal Health (NYSE:CAH) is a supplier of all sorts of solutions to the healthcare industry. From pharmaceuticals to surgical supplies to services that help hospitals better manage operations like billing and reimbursement, the well-established company keeps caregivers in action.The non-cyclical nature of the business doesn't mean the company doesn't face competition and headwinds though. Indeed, CAH stock has been cut in half since its early 2015 high, reaching new multi-year lows last week. Its performance has been so bad, in fact, that frustrated shareholders are now prepping class-action suits.In the midst of that frenzied doubt is when CAH stock could be most trade-worthy, however. It just topped its quarterly-earnings expectations, earning $1.11 versus estimates of only 93 cents. And the pros are calling for an earnings rebound this year. AT&T (T)Source: Shutterstock Dividend Yield: 5.9% Forward P/E: 9.6AT&T (NYSE:T) took its eye off the ball in 2016. Admittedly, the long-belabored effort to acquire Time Warner was distracting, but the telecom giant's woes weren't just related to that difficult deal. Its DirecTV acquisition has created more problems than profit, and the company seemingly became complacent with its position as the No. 2 wireless provider in the United States.There's a reason T stock is up almost 30% from its late-December low, however, snapping out of a long-standing downtrend in the process. And, Time Warner isn't a core part of the bullish rationale. Investors are starting to realize what the advent of 5G could mean for the telecom market, and for AT&T in particular. * 10 Stocks Under $5 to Buy for Fall As Will Healy put it last week, "the 5G network that burdened the company for years may soon give AT&T a level of pricing power not seen since its days as a monopoly. Moreover, even if T stock stagnates in the near-term, investors can collect a generous, increasing dividend." Ryder System (R)Source: Shutterstock Dividend Yield: 4.4% Forward P/E: 8.3Most investors will recognize the name Ryder System (NYSE:R) as the company that rents moving vans and self-driven trucks to consumers, and that's certainly a key part of its business. The company is so much more than that, however. Ryder also arranges for long-term corporate leases of heavy haulers, offers fleet maintenance services and will even manage the delivery aspect of a supply chain for its customers.It's anything but a recession-proof business. And, with the economy seemingly slowing down against a backdrop of never-ending tariff chatter, R stock doesn't feel like the safest name to own.With a yield of 4.4% and the equally good chance that the global economy is going to be rekindled by an eventual end to the tariff war though, Ryder System is arguably too cheap to pass up at less than nine times next year's expected earnings. Citigroup (C)Source: Shutterstock Dividend Yield: 3.1% Forward P/E: 7.8Finally, add Citigroup (NYSE:C) to your list of dividend stocks to buy sooner rather than later.Yes, it certainly appears to be in the wrong place at the wrong time. Lower interest rates make the business of lending money less profitable by compressing the spread between its costs of capital and what it's able to charge borrowers. And, two weeks ago the big bank confirmed it … its reducing its base lending rate by a quarter of a percentage, from 5.5% to 5.25%. The move impacted all new loans made since Aug. 1.The assumptions about the depth of the impact may be overblown though. Even as he was explaining the rationale for last month's quarter-point rate cut, Federal Reserve Chairman Jerome Powell was already cautioning that the FOMC reserves the right to ramp up rates again if it sees any hint of unchecked inflation. Reading between the lines, it's a subtle clue that the Fed doesn't want to cut rates again when it will have a chance to in September. * 7 5G Stocks to Buy Now for the Future All the worst possible news may already be priced into C stock, and more.As of this writing, James Brumley held a long position in AT&T. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks Under $5 to Buy for Fall * 5 Stocks to Avoid Amid the Ongoing Trade War * 7 5G Stocks to Buy Now for the Future The post 10 Cheap Dividend Stocks to Load Up On appeared first on InvestorPlace.
- ACCESSWIRE
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Chemours (CC)
NEW YORK, NY / ACCESSWIRE / August 8, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Chemours Company (“Chemours” or the “Company”) (NYSE:CC) ...
- Motley Fool
Here's Why Chemours Stock Fell 20.5% in July
Investors were anticipating weak second-quarter 2019 operating results. They were right.
Motley FoolThe Chemours Company (CC) Q2 2019 Earnings Call Transcript
CC earnings call for the period ending June 30, 2019.
- American City Business Journals
Local companies impacted by trade war-fueled stock market decline
Among the Philadelphia region’s largest 20 publicly traded companies, three in the chemical industry experienced the biggest dips in midday trading.
- PR Newswire
Chemours Acquires Mining Operations of Southern Ionics Minerals
WILMINGTON, Del., Aug. 2, 2019 /PRNewswire/ -- The Chemours Company (Chemours) (CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, today announced the acquisition of Southern Ionics Minerals, LLC (SIM), a minerals exploration, mining, and manufacturing company headquartered in Jacksonville, Florida. SIM was a wholly owned subsidiary of Southern Ionics Incorporated (SII), a privately held inorganic chemical manufacturer based in West Point, Mississippi. SIM mines and processes titanium and zirconium mineral sands from a similar geological formation as those produced by Chemours at the company's existing mineral sands mine in Florida.
- American City Business Journals
Chemours CEO addresses disappointing results
Chemours also announced a $25 million acquisition of a mineral mining and manufacturing firm in Florida.
- Zacks
Chemours' (CC) Earnings and Revenues Miss Estimates in Q2
Weak demand for Ti-Pure TiO2 and Illegal imports of HFC refrigerants hurt Chemours (CC) in Q2.
